Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial

被引:29
|
作者
Castellsague, Xavier [1 ]
Paavonen, Jorma [2 ]
Jaisamrarn, Unnop [3 ]
Wheeler, Cosette M. [4 ,5 ]
Skinner, S. Rachel [6 ,7 ]
Lehtinen, Matti [8 ]
Naud, Paulo [9 ]
Chow, Song-Nan [10 ]
Del Rosario-Raymundo, Maria Rowena [11 ]
Teixeira, Julio C. [12 ]
Palmroth, Johanna [13 ]
de Carvalho, Newton S. [14 ]
Germar, Maria Julieta V. [15 ]
Peters, Klaus [16 ]
Garland, Suzanne M. [17 ,18 ,19 ,20 ]
Szarewski, Anne [21 ]
Poppe, Willy A. J. [22 ]
Romanowski, Barbara [23 ]
Schwarz, Tino F. [24 ,25 ]
Tjalma, Wiebren A. A. [26 ]
Bosch, F. Xavier [1 ,27 ]
Bozonnat, Marie-Cecile [28 ]
Struyf, Frank [29 ]
Dubin, Gary [30 ]
Rosillon, Dominique [29 ]
Baril, Laurence [29 ]
机构
[1] CIBER ESP, Canc Epidemiol Res Program, Unit Infect & Canc, IDIBELL,Inst Catala Oncol, Avda Gran Via 199-203, Barcelona 08908, Catalonia, Spain
[2] Univ Helsinki, Dept Obstet & Gynaecol, Helsinki, Finland
[3] Chulalongkorn Univ, Dept Obstet & Gynaecol, Fac Med, Bangkok 10330, Thailand
[4] Univ New Mexico, Hlth Sci Ctr, Dept Pathol, Albuquerque, NM 87131 USA
[5] Univ New Mexico, Hlth Sci Ctr, Dept Obstet & Gynecol, Albuquerque, NM 87131 USA
[6] Telethon Inst Child Hlth Res, Vaccines Trials Grp, Perth, WA, Australia
[7] Childrens Hosp Westmead, Sydney Univ Discipline Paediat & Child Hlth, Sydney, NSW, Australia
[8] Univ Tampere, Sch Publ Hlth, FIN-33101 Tampere, Finland
[9] Univ Fed Rio Grande do Sul, Dept Gynecol & Obstet, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil
[10] Natl Taiwan Univ, Dept Obstet & Gynecol, Coll Med & Hosp, Taipei 10764, Taiwan
[11] San Pablo Coll Med Ctr, San Pablo City, Laguna, Philippines
[12] Univ Estadual Campinas, UNICAMP, Dept Tocoginecol, Sao Paulo, Brazil
[13] Cent Hosp North Carelian, Dept Obstet & Gynecol, Joensuu, Finland
[14] Univ Fed Parana, Infect Dis Gynecol & Obstet Sect, Dept Gynecol & Obstet, BR-80060000 Curitiba, Parana, Brazil
[15] Univ Philippines Coll Med, Philippines Gen Hosp, Dept Obstet & Gynecol, Manila, Philippines
[16] Facharzt Frauenheilkunde & Geburtshilfe, Hamburg, Germany
[17] Royal Womens Hosp, Dept Microbiol & Infect Dis, Parkville, Vic, Australia
[18] Royal Childrens Hosp, Dept Microbiol, Parkville, Vic 3052, Australia
[19] Murdoch Childrens Res Inst, Parkville, Vic, Australia
[20] Univ Melbourne, Dept Obstet & Gynaecol, Parkville, Vic 3052, Australia
[21] Queen Mary Univ London, Wolfson Inst Prevent Med, Ctr Canc Prevent, London, England
[22] Univ Hosp KU Leuven Gasthuisberg, Dept Gynaecol, Leuven, Belgium
[23] Univ Alberta, Dept Med, Fac Med & Dent, Div Infect Dis, Edmonton, AB, Canada
[24] Univ Wurzburg, Stiftung Juliusspital, Acad Teaching Hosp, Cent Lab, D-97070 Wurzburg, Germany
[25] Univ Wurzburg, Stiftung Juliusspital, Acad Teaching Hosp, Vaccinat Ctr, D-97070 Wurzburg, Germany
[26] Univ Antwerp, Multidisciplinary Breast Clin & Gynaecol Oncol, Univ Antwerp Hosp, B-2020 Antwerp, Belgium
[27] RTICC, Network Cooperat Canc Res, Catalonia, Spain
[28] 4Clin, Paris, France
[29] GlaxoSmithKline Vaccines, Wavre, Belgium
[30] GlaxoSmithKline Vaccines, King Of Prussia, PA USA
关键词
HPV; CIN; Sexual intercourse; Time; Risk; HUMAN-PAPILLOMAVIRUS INFECTION; CHLAMYDIA-TRACHOMATIS INFECTION; NATURAL-HISTORY; YOUNG-WOMEN; FOLLOW-UP; PERSISTENCE; CANCER; COHORT; COINFECTION; ACQUISITION;
D O I
10.1186/s12879-014-0551-y
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: More information is needed about time between sexual initiation and human papillomavirus (HPV) infection and development of cervical precancer. Methods: The objectives were to investigate the time between first sexual activity and detection of first cervical HPV infection or development of first cervical intraepithelial neoplasia (CIN), and associated factors in women from the double-blind, multinational, 4-year PATRICIA trial. PATRICIA enroled women aged 15-25 years with no more than 6 lifetime sexual partners. Women were randomized 1:1 to the HPV-16/18 AS04-adjuvanted vaccine or to control, but only women from the control arm who began sexual intercourse during the study or within 6 months before enrolment, and had no HPV infection detected before the recorded date of their first sexual intercourse, were included in the present analysis. The time between onset of sexual activity and detection of the first cervical HPV infection or development of the first CIN lesion was analyzed using Kaplan-Meier and univariate and multivariable Cox proportional-hazards models. Results: A total of 9337 women were enroled in the control arm of PATRICIA of whom 982 fulfilled the required inclusion criteria for analysis. A cumulative total of 28%, 44%, and 62% of the subjects had HPV infection within 12, 24, and 48 months, respectively. The overall incidence rate was 27.08 per 100 person-years. The most common oncogenic types associated with 6-month persistent infection were HPV-16 (incidence rate: 2.74 per 100 person-years), HPV-51 (2.70), HPV-52 (1.66), HPV-66 (1.14), and HPV-18 (1.09). Increased infection risk was associated with more lifetime sexual partners, being single, Chlamydia trachomatis history, and duration of hormone use. CIN1+ and CIN2+ lesions were most commonly associated with HPV-16, with an overall incidence rate of 1.87 and 1.07 per 100 person-years, respectively. Previous cervical HPV infection was most strongly associated with CIN development. Conclusions: More than 25% of women were infected with HPV within 1 year of beginning sexual activity. Without underestimating the value of vaccination at older ages, our findings emphasize its importance before sexual initiation.
引用
收藏
页数:12
相关论文
共 4 条
  • [1] Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial
    Xavier Castellsagué
    Jorma Paavonen
    Unnop Jaisamrarn
    Cosette M Wheeler
    S Rachel Skinner
    Matti Lehtinen
    Paulo Naud
    Song-Nan Chow
    Maria Rowena Del Rosario-Raymundo
    Julio C Teixeira
    Johanna Palmroth
    Newton S de Carvalho
    Maria Julieta V Germar
    Klaus Peters
    Suzanne M Garland
    Anne Szarewski
    Willy AJ Poppe
    Barbara Romanowski
    Tino F Schwarz
    Wiebren AA Tjalma
    F Xavier Bosch
    Marie-Cecile Bozonnat
    Frank Struyf
    Gary Dubin
    Dominique Rosillon
    Laurence Baril
    BMC Infectious Diseases, 14
  • [2] Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study
    Skinner, S. Rachel
    Wheeler, Cosette M.
    Romanowski, Barbara
    Castellsague, Xavier
    Lazcano-Ponce, Eduardo
    Rowena Del Rosario-Raymundo, M.
    Vallejos, Carlos
    Minkina, Galina
    Da Silva, Daniel Pereira
    McNeil, Shelly
    Prilepskaya, Vera
    Gogotadze, Irina
    Money, Deborah
    Garland, Suzanne M.
    Romanenko, Viktor
    Harper, Diane M.
    Levin, Myron J.
    Chatterjee, Archana
    Geeraerts, Brecht
    Struyf, Frank
    Dubin, Gary
    Bozonnat, Marie-Cecile
    Rosillon, Dominique
    Baril, Laurence
    INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (10) : 2428 - 2438
  • [3] Quantitative methylation analysis to detect cervical (pre)-cancerous lesions in high-risk HPV-positive women
    Yuan, Liqin
    Hu, Yuanjing
    Zhou, Zijing
    Gong, Yingying
    Wang, Rong
    Li, Na
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (07): : 10577 - 10586
  • [4] Efficacy of Human Papillomavirus 16 and 18 (HPV-16/18) AS04-Adjuvanted Vaccine against Cervical Infection and Precancer in Young Women: Final Event-Driven Analysis of the Randomized, Double-Blind PATRICIA Trial
    Apter, Dan
    Wheeler, Cosette M.
    Paavonen, Jorma
    Castellsague, Xavier
    Garland, Suzanne M.
    Skinner, S. Rachel
    Naud, Paulo
    Salmeron, Jorge
    Chow, Song-Nan
    Kitchener, Henry C.
    Teixeira, Julio C.
    Jaisamram, Unnop
    Limson, Genara
    Szarewski, Anne
    Romanowski, Barbara
    Aoki, Fred Y.
    Schwarz, Tino F.
    Poppe, Willy A. J.
    Xavier Bosch, F.
    Mindel, Adrian
    De Sutter, Philippe
    Hardt, Karin
    Zahaf, Toufik
    Descamps, Dominique
    Struyf, Frank
    Lehtinen, Matti
    Dubin, Gary
    CLINICAL AND VACCINE IMMUNOLOGY, 2015, 22 (04) : 361 - 373